Trial Information
A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
Inclusion Criteria:
- All patients undergoing curative or palliative treatment in whom it is considered
that immobilization of part or all of an anatomical region would be of benefit to
their care.
Exclusion Criteria:
- Any case where ideal treatment may be compromised with use of immobilization method.
- If the patient has any social issues, language barriers resulting in difficulties
comprehending the nature of the study, or poor performance status, that could
compromise compliance with the study guidelines.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The primary outcome for the study is the average deviation in set-up.
Principal Investigator
Alex Sun, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Princess Margaret Hospital, Canada
Authority:
Canada: Ethics Review Committee
Study ID:
UHN REB 02-0526-C
NCT ID:
NCT00232440
Start Date:
January 2003
Completion Date:
June 2009
Related Keywords:
- Hodgkin's Disease
- Lymphoma, Non-Hodgkin
- Hodgkin Disease
- Lymphoma
- Lymphoma, Non-Hodgkin